Spherical IOL provides a higher CDVA compared to aspheric lens

Article

Fitting a spherical acrylic intraocular lens (IOL) in patients with bilateral cataract improves corrected distance visual acuity (CDVA) more so than fitting an aspheric IOL.

Fitting a spherical acrylic intraocular lens (IOL) in patients with bilateral cataract improves corrected distance visual acuity (CDVA) more so than fitting an aspheric IOL, claims an investigation featured in Journal of Cataract and Refractive Surgery.

Dr Manickam Thiagarajan and his team, Eye Department, Southampton University Hospital, UK, conducted a randomized, masked, single-centre study on bilateral cataract patients aged 50 years and over. The biometry-predicted IOL power was between 10.0 D and 30.0 D. Patients were fitted with the Akreos Adapt Advanced Optics aspheric IOL and the Sensar AR40e spherical acrylic IOL.

A high-contrast logMAR chart was used to measure CDVA, the Pelli-Robson chart was used to measure contrast sensitivity, range of accommodation was measured using the RAF rule and patient satisfaction was recorded by questionnaire 3 months postoperatively. Pseudoaccommodation, mesopic pupil diameters and scotopic pupil diameters were all measured with a power refractor.

The difference in mean CDVA between the IOLs was 0.015, with the spherical IOL scoring the highest. The differences between contrast sensitivity and range of accommodation were 0.02 and 0.05, respectively. The questionnaire answers produced no differences in dysphotopsia and patient satisfaction.

The spherical IOL demonstrated a statistically significant improvement in CDVA but the findings are not clinically important.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.